Seven years in stealth. Built by doctors, scientists, engineers, architects, platform strategists, technologists, and lawyers WHO SHIP.
PJ Vance
Founder & CTO
Technology bioengineer and full-stack solution architect of the multiscale causal model. Sets platform direction and scientific standards.
Senior Executive Data Scientist based in Basel, Switzerland, with 25+ years of experience across FinTech, MedTech, & TechBio, including full-stack platforms, multimodal machine learning, hybrid AI, biomimicry, and cryptology. A visionary logical systems thinker and collaborative problem solver who translates limits challenging frontier-level complex science and technology into scalable, high-impact solutions, and carries critical initiatives from concept through execution.
Thomas Curtiss
Chief Business Development Officer
Former Eli Lilly C-suite. Structures milestone-gated pharma partnerships and co-development options.
A former Eli Lilly C-suite business development executive, venture investor, and pharmaceutical strategist, he brings more than 25+ years of experience in technology scouting, investment evaluation, strategic partnerships, licensing, and mergers and acquisitions. Curtiss transforms visionary frontier science into commercial value by advancing innovations into fundable, partner-ready, and commercially compelling businesses.
William Gilman
Chief Operating Officer
Runs the operating cadence between virtual perturbation, wet-lab validation, and partner delivery.
Former UBS Investment Services Managing Director and Regional COO with deep expertise in developing complex financial products, building strategic alliances, and defining front-to-back roadmaps for derivatives, trade lifecycles, and hedge fund services. Proven leader in bridging business strategy with FinTech, IT, & OP teams to deliver secure, scalable trading platforms, algorithmic solutions, data infrastructure, automation, and robotics.
Sarah Decembrini
Senior Scientist + Lab Director
Experienced scientist in organoids, microfluidics, gene and cell therapies. Runs virtual pre-clinical programs and translational validation.
Deeply experienced advanced senior BioPharma scientist recognized for combining deep techbio insight with strong frontier product development and project leadership skills. Sarah is driven by a commitment to advancing translational research that brings novel therapies closer to patients.
Rahul Girish
Director of Development
Leads product development and delivery across advanced multimodal computational simulation, complex geometry, and digital fabrication — integrating dry-lab computational design, wet-lab experimental validation, and robotic automation.
Rahul brings ten years of product innovation experience, combining architectural training with advanced technical expertise to deliver transformative solutions. His multidisciplinary background spans parametric design, computation, complex geometries, digital fabrication, robotics, and automation. He translates intricate geometric biostructures into reproducible computational models that support simulation, mechanistic insight, and reverse bioengineering. A technical thought leader and practical problem solver, Rahul turns pioneering concepts into working capabilities.
Daniel Christev
Director of Engineering
Leads biomechanical systems engineering, agentic algorithm development, and digital quadruplet architecture for biosystems — integrating 10D+ simulation models, causal relationship layers, and adaptive control systems.
Dan brings ten years of results-driven engineering experience, combining logical precision, lateral thinking, and deep technical expertise to solve complex challenges and deliver on time. Trained in mechanical engineering and building architecture, he applies a distinctive structural systems perspective to reverse bioengineering and programmable biology. His grounded, inventive approach advances BIOALGX biological tool development and tackles demanding algorithmic and simulation problems. He values knowledge-sharing, continuous learning, and thoughtful, committed collaboration.
Catalin Cobzaru
AI & Software Engineering Manager
Leads the development and delivery of cryptographically secured AI systems and customer-facing discovery and design software, aligning service agreements and technical delivery with scientific objectives.
Leads the development and delivery of cryptographically secured AI systems and customer-facing discovery and design software, aligning service agreements and technical delivery with scientific objectives.
